IPG Investment Advisors’s Pfizer PFE Stock Holding History

IPG Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,550	Closed	-$521K	–	288
2026 Q1	$521K	Buy	18,550 +5,400	+41%	+$144K	0.09%	139
2025 Q4	$327K	Sell	13,150 -3,850	-23%	-$97.1K	0.06%	161
2025 Q3	$433K	Buy	+17,000	New	+$420K	0.08%	141
2022 Q1	–	Sell	-18,922	Closed	-$1.12M	–	208
2021 Q4	$1.12M	Buy	+18,922	New	+$938K	0.2%	68
2021 Q2	–	Sell	-8,613	Closed	-$312K	–	207
2021 Q1	$312K	Buy	+8,613	New	+$306K	0.06%	147
2020 Q4	–	Sell	-10,937	Closed	-$381K	–	187
2020 Q3	$381K	Buy	+10,937	New	+$383K	0.11%	97
2018 Q4	–	Sell	-10,273	Closed	-$430K	–	173
2018 Q3	$430K	Buy	10,273 +1,661	+19%	+$63.9K	0.14%	94
2018 Q2	$296K	Hold	8,612	–	–	0.1%	114
2018 Q1	$290K	Buy	8,612 +2,108	+32%	+$72.5K	0.09%	113
2017 Q4	$224K	Buy	6,504 +527	+9%	+$18K	0.09%	125
2017 Q3	$202K	Buy	+5,977	New	+$192K	0.07%	126
2016 Q4	–	Sell	-7,795	Closed	-$251K	–	143
2016 Q3	$251K	Sell	7,795 -580	-7%	-$19.4K	0.11%	95
2016 Q2	$280K	Buy	+8,375	New	+$267K	0.12%	98

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

IPG Investment Advisors's PFE Position: Q2 2026 in Review

IPG Investment Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 18,550 shares — an estimated $521K sold.

IPG Investment Advisors first reported a position in PFE in Q2 2016 and held it in 13 quarters. The position peaked at $1.12M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

IPG Investment Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
IPG Investment Advisors sold 18,550 Pfizer shares in Q2 2026, an estimated $521K.
IPG Investment Advisors first reported a position in Pfizer in Q2 2016 and held it in 13 quarters.
IPG Investment Advisors's Pfizer position peaked at $1.12M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on IPG Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.